Open-label Extension Study to Evaluate the Long-term Safety of Cenobamate Adjunctive Therapy in Subjects with Primary Generalized Tonic- Clonic Seizures

Open-label Extension Study to Evaluate the Long-term Safety of Cenobamate Adjunctive Therapy in Subjects with Primary Generalized Tonic- Clonic Seizures

Brief description of study

The research study is being conducted to evaluate the long-term safety and tolerability of cenobamate for Primary Generalized Tonic-Clonic (PGTC) seizures

Detailed description of study

 You are being invited to participate in this study because you have completed main study YKP3089C025.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    epilepsy,seizures
  • Age: Between 18 Years - 99 Years
  • Gender: All


Updated on 29 May 2023. Study ID: 834015

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center